TP53 and breast carcinoma: Similar to our cohort, while initially reported in cases of pediatric adrenocortical carcinoma patients, large-scale studies have since described breast cancer as the most common tumor in carriers of TP53 p.Arg337His with later onset in comparison to classical LFS [35, 37].